DOI:
10.1055/s-00025479
Experimental and Clinical Endocrinology & Diabetes Reports
LinksClose Window
References
Neggers SJ, de Herder WW, Feelders RA. et al.
Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients.
Pituitary 2011;
14: 253-258
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.